Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

Clinical trial NCT01863680 · COMPLETED

Trial details

NCT number: NCT01863680
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Luteal Hormone Supplementation in In-vitro Fertilization Embryo Transfer

Start date: 2013-07-01
Primary completion: 2014-10-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.